Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska

Anthony R. Sambol, Steven H. Hinrichs, Wayne R. Hogrefe, Beth K. Schweitzer

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

In 2003, the Nebraska Public Health Laboratory tested more than 10,371 serum and 516 cerebral spinal fluid specimens. Results showed that without performing the interfering factors screen for specimens in the low positive index value range of >1.1 to ≤3.5, a false positivity rate of 6.5% would have been realized.

Original languageEnglish (US)
Pages (from-to)87-89
Number of pages3
JournalClinical and Vaccine Immunology
Volume14
Issue number1
DOIs
StatePublished - Jan 2007

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska'. Together they form a unique fingerprint.

  • Cite this